Skip to content

868459108SUPERNUS PHARMACEUTICALS

CUSIP 868459108 · common stock

4 tracked investors held SUPERNUS PHARMACEUTICALS (868459108) at the end of Q3 2026, worth $18.3M in total. The largest holder was Bruce & Co, with 2.3% of its portfolio. Joel Greenblatt sold out of its position this quarter.

Holders · Q3 2026
4
New holders
0
Value held
$18.3M
Quarter-end price (est.)
$43.04

Investors holding 868459108 · Q3 2026

InvestorWeightSharesValueChange
Bruce & Co
Bruce & Co., Inc.
2.33%200,000$8.6MADD+33.3%
Third Avenue Management
Third Avenue Management LLC
1.13%157,150$6.8MADD+2.9%
Chuck Royce
Royce & Associates LP
0.02%40,385$1.7MADD+2.2%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.05%27,842$1.2MHOLD

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Joel Greenblatt0.00%7,422$345.2KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026401$18.3M$43.04
Q2 2026510$17.6M$46.51
Q1 2026401$26.5M$51.69
Q4 2025500$25M$49.70